End-to-End Biotech Expertise

Strategic and Scientific Advice
The path to a mature product is long and complex, with many strategic choices and potential pitfalls—especially in the early stages. Knowing which questions to ask and how to shape your product profile is critical for an efficient development strategy.
That’s why we offer a free session with our cross-functional Strategic Advice Group. Led by our Medical Director and senior experts, the group works in close partnership with you to clarify priorities, assess risks, and provide guidance to reduce time, costs, and resource waste in product development.

Drug Development /
Pre-Marketing Regulatory Services
Developing a new biotech product can be complex, especially when navigating regulatory requirements before clinical trials. Let LINK Medical’s Nordic regulatory experts guide your team.
We support biotech companies through every stage of early development—from CMC (Chemistry, Manufacturing & Controls) to non-clinical and clinical phases. Our experts ensure your strategy meets current standards, minimizes risks, and accelerates your path to first-in-human studies and beyond.

Full-Service Phase II-IV Clinical Trials
LINK Medical CRO brings advanced expertise in clinical trial methodology across all phases, for any indication or level of complexity. Our regulatory team provides strong support for biotech companies, covering both pre- and post-marketing services, including CMC and compliance review.

Early Phase FIH /
Phase I Clinical Trial Package
With our two in-house, state-of-the-art clinical research units, we offer full-service Phase I trial packages—from study design to final reports—backed by 30+ years of experience.
Our Phase I expertise covers clinical pharmacology studies in healthy volunteers and patients, for small-molecule NCEs, biologics, and vaccines. We deliver tailored solutions while providing the scientific, clinical, and regulatory expertise needed to achieve study objectives successfully.
590 +
clinical trials
150 +
employees
20 +
therapeutic areas
6
countries
